A clinical study to see effect of Amlapittahar syrup in hyperacidity.

An open labelled prospective randomized controlled phase 2 clinical study to evaluate efficacy of Amlapittahar syrup for Urdhwag Amlapitta [Hyperacidity] - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/092215

Enrollment

120

Registered

2025-08-01

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere Health Condition 2: K82- Other diseases of gallbladder

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: patients having symptoms of Amlapitta like chardi Amlodgar Shirshul Avipak malavasthamba Both the sex Male and Female Patients from all socio-economical status

Exclusion criteria

Exclusion criteria: Patient below 19 yrs and above 60 yrs . patient of adhoga amlapitta Patient having hepatic disorder and other complication patient suffering from major illness like stomach cancer and other illness

Design outcomes

Primary

Measure	Time frame
Decrease in signs & symptoms of urdhawg amlapitta.Timepoint: 4 weeks	—

Secondary

Measure	Time frame
To evaluate the efficiency of Guduchyadi Syrup for Amlapitta on Symptoms such as Aruchi, Amloudar ,Avipak,Chhardi, Ridhyadaha DoTimepoint: 15 months	—

Countries

India

Contacts

Public ContactDr Sheetal Chavan

dr.sheetalyadav59@gmail.com9272642873

Outcome results